These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2043377)

  • 21. Cataracts in myotonic dystrophy.
    Grala PE
    J Am Optom Assoc; 1983 Dec; 54(12):1067-8. PubMed ID: 6655188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urinary stress incontinence as the presenting feature of myotonic dystrophy.
    Dickson MJ; Massiah N; Church E
    J Obstet Gynaecol; 2012 Jan; 32(1):102. PubMed ID: 22185554
    [No Abstract]   [Full Text] [Related]  

  • 23. Gastroparesis in neonatal myotonic dystrophy.
    Bodensteiner JB; Grunow JE
    Muscle Nerve; 1984; 7(6):486-7. PubMed ID: 6543902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beneficial effect of digitoxin for heart failure from noncompaction in myotonic dystrophy 1.
    Finsterer J; Stöllberger C
    Int J Cardiol; 2012 Oct; 160(3):e50-1. PubMed ID: 22475848
    [No Abstract]   [Full Text] [Related]  

  • 25. Anorectal incontinence in myotonic dystrophy: a myopathic involvement of pelvic floor muscles.
    Herbaut AG; Nogueira MC; Panzer JM; Zegers de Beyl D
    Muscle Nerve; 1992 Oct; 15(10):1210-1. PubMed ID: 1406779
    [No Abstract]   [Full Text] [Related]  

  • 26. Giardia lamblia infection in a patient with myotonic dystrophy.
    Mouthon L; Godmer P; Piqueras B; Cohen P; Lortholary O; Hofmann-Radvanyi H; Guillevin L
    Ann Med Interne (Paris); 2002 Dec; 153(8):540-2. PubMed ID: 12610429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac Abnormalities in Congenital and Childhood Myotonic Muscular Dystrophy Type 1.
    Sharma A; Singh S; Mishra SK
    Neuropediatrics; 2017 Feb; 48(1):42-44. PubMed ID: 27992942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Duchenne muscular dystrophy and myotonic dystrophy in the same patient.
    Dubrovsky AL; Taratuto AL; Sevlever G; Schultz M; Pegoraro E; Hoop RC; Hoffman EP
    Am J Med Genet; 1995 Jan; 55(3):342-8. PubMed ID: 7726234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term Safety and Efficacy of Mexiletine in Myotonic Dystrophy Types 1 and 2.
    Mousele C; Matthews E; Pitceathly RDS; Hanna MG; MacDonald S; Savvatis K; Carr A; Turner C
    Neurol Clin Pract; 2021 Oct; 11(5):e682-e685. PubMed ID: 34840883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Myotonic dystrophy with progressive muscular dystrophy and atypical Adie syndrome].
    HORVAT J; TADIC N
    Med Arh; 1957; 11(6):127-38. PubMed ID: 13516150
    [No Abstract]   [Full Text] [Related]  

  • 31. Myotonic dystrophy type 1 drug development: A pipeline toward the market.
    Pascual-Gilabert M; López-Castel A; Artero R
    Drug Discov Today; 2021 Jul; 26(7):1765-1772. PubMed ID: 33798646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of muscular dystrophy with laevadosin.
    Das Gupta A
    J Indian Med Assoc; 1969 Oct; 53(8):390-2. PubMed ID: 5369189
    [No Abstract]   [Full Text] [Related]  

  • 33. Pilomatricomas associated with myotonic dystrophy.
    Chiaramonti A; Gilgor RS
    Arch Dermatol; 1978 Sep; 114(9):1363-5. PubMed ID: 686751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. There is no smoke without fire: myotonic muscular dystrophy and Brugada syndrome.
    Kozak HH; Ulvi Uca A; Altaş M
    J Clin Neuromuscul Dis; 2014 Mar; 15(3):88-9. PubMed ID: 24534828
    [No Abstract]   [Full Text] [Related]  

  • 35. [Problems of physiopathology and clinical aspects of the fundamental extra-muscular ocular manifestations of myotonic dystrophy].
    Nappi G; Poloni M; Manfredini U; Scelsi R
    Riv Neurol; 1977; 47(6):710-27. PubMed ID: 601449
    [No Abstract]   [Full Text] [Related]  

  • 36. [A case of coexisting myotonic dystrophy and muscular tuberculosis].
    Hański W; Kruszyński J
    Neuropatol Pol; 1967; 5(3):365-70. PubMed ID: 6077957
    [No Abstract]   [Full Text] [Related]  

  • 37. [Cardiac, respiratory and sleep disorders in patients with myotonic dystrophy].
    Banach M; Rakowicz M; Antczak J; Rola R; Witkowski G; Waliniowska E
    Przegl Lek; 2009; 66(12):1065-8. PubMed ID: 20514907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Myotonia with muscular weakness corrected by exercise. The therapeutic effect of mexiletine].
    Pouget J; Serratrice G
    Rev Neurol (Paris); 1983; 139(11):665-72. PubMed ID: 6677978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pain in myotonic muscular dystrophy, type 1.
    Carter GT; Jensen MP; Hoffman AJ; Stoelb BL; Abresch RT; McDonald CM
    Arch Phys Med Rehabil; 2008 Dec; 89(12):2382. PubMed ID: 19061752
    [No Abstract]   [Full Text] [Related]  

  • 40. Selenium therapy of myotonic dystrophy.
    Orndahl G; Rindby A; Selin E
    Acta Med Scand; 1983; 213(3):237-9. PubMed ID: 6846068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.